1,3,7-Trihydroxy-2-(3-methylbut-2-en-1-yl)-9H-xanthen-9-one | CAS 20245-39-0

Element: trihydroxy methylbut xanthen

Page Content Identification Properties Suppliers Prices & Availability Get Quick Quote ☰

Identification Properties Suppliers Prices & Availability Get Quick Quote

C-S » Chemicals » trihydroxy-methylbut-xanthen-one-PX1604290

Identification

1,3,7-Trihydroxy-2-(3-methylbut-2-en-1-yl)-9H-xanthen-9-one

CAS:

20245-39-0

EINECS:

Molecular Formula:

C₁₈H₁₆O₅

MDL:

Synonym:

9H-Xanthen-9-one, 1,3,7-trihydroxy-2-(3-methyl-2-butenyl)-

Suppliers

Get Quick Quote

CAS equal suppliers

1,3,7-Trihydroxy-2-prenylxanthone

Leap Chem Co., Ltd

LC11883564

1,3,7-Trihydroxy-2-prenylxanthone

Dayang Chem (Hangzhou) Co.,Ltd.

DC20468184

1,3,7-Trihydroxy-2-prenylxanthone

BOC Sciences

BS7922376

Prices & Availability

Data is processed

Properties for 1,3,7-Trihydroxy-2-(3-methylbut-2-en-1-yl)-9H-xanthen-9-one

Safety & Transport Information

coming up soon

Alternative Distributors of [1,3,7-Trihydroxy-2-(3-methylbut-2-en-1-yl)-9H-xanthen-9-one]

Producers or manufacturers change the product range from time to time. Currently there are no other manufacturers known.

Downloads

Mol File:

-/-

MSDS:

-/-

Related products

View related products

2,3,6,8-Tetrahydroxy-1-methyl-9H-xanthen-9-one

9-[p-(Dimethylamino)phenyl]-2,6,7-trihydroxy-3h-xanthen-3-one

7,9,12-Trihydroxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one

9H-xanthen-9-one, 1,3,5-trihydroxy-2,4-bis(3-methyl-2-butenyl)-

2H,6h-pyrano[3,2-b]xanthen-6-one, 7,9,12-trihydroxy-2,2-dimethyl-

9H-xanthen-9-one, 1,3,5,8-tetrahydroxy-2,4-bis(3-methyl-2-butenyl)-

1,3,5,8-Tetrahydroxy-2,4-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one

1,3,6-Trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-en-1-yl)-9H-xanthen-9-one

9H-Xanthen-9-one,1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methyl-2-buten-1-yl)-

1-((2-(Dimethylamino)ethyl)amino)-7-hydroxy-4-(hydroxymethyl)-9H-xanthen-9-one

2-[2-Chloro-6-hydroxy-5-(2-methylquinolin-8-ylamino)methyl]-3-oxo-3H-xanthen-9-ylbenzoic acid

N-[6-hydroxy-9-[2-(methoxycarbonyl)phenyl]-3H-xanthen-3-ylidene]-N,N-dimethylammonium chloride

Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,5-(aminomethyl)-3',6'-dihydroxy-, hydrochloride (1:1)

Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,4'-(aminomethyl)-3',6'-dihydroxy-, hydrochloride (1:1)

3,4-Dihydro-5,9-dihydroxy-8-methoxy-2,2-dimethyl-7-(3-methyl-2-butenyl)-2H,6H-pyrano[3,2-b]xanthen-6-one

2H,12H-Pyrano[2,3-a]xanthen-12-one,3,4-dihydro-5,9-dihydroxy-10-methoxy-2,2-dimethyl-11-(3-methyl-2-buten-1-yl)-

6-[(3,4-dihydroxyphenyl)methyl]-2,10-dihydroxy-5-(4-hydroxy-2-methoxyphenyl)-1,3-dimethoxy-9H-benzo[a]xanthen-9-one

N-[5-(Bis-carboxymethyl-amino)-5-carboxy-pentyl)]-2-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)-terephthalamic Acid

N-[5-(Bis-carboxymethyl-amino)-5-carboxy-pentyl)]-2-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)-terephthalamic Acid (NTA-DFC)

3-Amino-7-(dimethylamino)phenothiazin-5-ium, salt with 2,4,5,7-tetrabromo-3,6-dihydroxyspiro(isobenzofuran-1(3H),9-(9H)xanthen)-3-one (2:1)

3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium, salt with 2,4,5,7-tetrabromo-3,6-dihydroxyspiro(isobenzofuran-1(3H),9-(9H)xanthen)-3-one (2:1)

N-(1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)-2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetamide

5-[[[[2-[[(4S)-4-[[4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]amino]-4-carboxy-1-oxobutyl]amino]ethyl]amino]thioxomethyl]amino]-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid so